Nursing News and Research

Latest Nursing News and Research

CSL Behring selects BioRx as an approved Berinert provider

BioRx, a specialty pharmacy company, has been named one of a small number of approved providers of Berinert®. Berinert® is a plasma-derived concentrate of C1 esterase inhibitor (human) indicated for the treatment of acute abdominal or facial attacks of hereditary angioedema (HAE) in adult and adolescent patients. CSL Behring, the manufacturer of Berinert® selected BioRx as part of their distribution network to launch this exciting new product in the United States.

8 Dec 2009

Utah project seeks to reduce 'overuse of health care'

News outlets report on a pilot project in Utah to reduce overuse of services and Medicaid cuts in Kansas.

8 Dec 2009

Moses Cone Health System to implement Streamline Health Solutions' enterprise technology

Streamline Health Solutions, Inc. a leading provider of document workflow solutions for hospitals, today announced that Moses Cone Health System has selected the Company's enterprise technology to improve quality and operating efficiency by providing their physicians with one view of the patient medical record across their healthcare enterprise.

8 Dec 2009

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Millennium: The Takeda Oncology Company today reported the presentation of results from a double randomized Phase III clinical trial of VELCADE based combinations for the treatment of patients with previously untreated multiple myeloma (MM). The VELCADE based combinations evaluated in the study demonstrated two-year overall survival rates ranging between 81 and 88 percent.

8 Dec 2009

Experts attribute increased demand for nursing jobs to rise in pediatric specialty services

A shift upward in the number of children treated by hospitals and outpatient facilities nationwide has created a spike in the demand for pediatric nurses, resulting in high pay and exceptional benefits for these positions.

8 Dec 2009

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

Celgene International Sàrl announced that data evaluating combination therapy REVLIMID (lenalidomide) and dexamethasone in patients with high-risk smoldering multiple myeloma were presented during the American Society of Hematology’s annual meeting in New Orleans, LA. The landmark study demonstrated REVLIMID and dexamethasone prolonged time to progression, including complete responses, with manageable toxicity.

8 Dec 2009

ISST researchers develop software for physicians to have weekly 'Wound Conference'

Wounds suffered by patients with diabetes tend to heal poorly. For treatment to work, the patient's physician must discuss the situation with specialists and nursing staff to decide on the best approach. However, e-mailing the files containing the diagnosis and discussing them on the telephone is a time-consuming process.

8 Dec 2009

Study results comparing REVLIMID regimen to stem cell transplant in multiple myeloma patients

Celgene International Sàrl announced clinical data from an investigational study of patients with multiple myeloma who were younger than 65 years old and received either REVLIMID (lenalidomide), melphalan and prednisone (MPR) or melphalan plus autologous stem cell transplant (MEL200) following an induction treatment of REVLIMID plus low-dose dexamethasone (Rd) were presented during the 51st American Society of Hematology’s annual meeting in New Orleans, LA.

8 Dec 2009

Human blood stem cells can be engineered to kill HIV-infected cells, find researchers

Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells — a process that potentially could be used against a range of chronic viral diseases.

8 Dec 2009

New pharmacology textbook released by Elsevier

Elsevier, the world-leading publisher of scientific, technical and medical information products and services, proudly announces the early success and rapid acceptance of its recently released Pharmacology and Therapeutics: Principles to Practice, an innovative new pharmacology textbook designed to better meet the needs of today's residents and practitioners.

8 Dec 2009

Workforce Alliance receives $134,790 grant to fund workforce training program

Workforce Alliance was awarded a $134,790 grant by the State of Florida to fund a workforce training program aimed at meeting the high need for skilled health care workers in Palm Beach County.

8 Dec 2009

Investigation: Temp firms often employ incompetent nurses

"Firms that supply temporary nurses to the nation's hospitals are taking perilous shortcuts in their screening and supervision, sometimes putting seriously ill patients in the hands of incompetent or impaired caregivers," ProPublica and The Los Angeles Times report. "Emboldened by a chronic nursing shortage and scant regulation, the firms vie for their share of a free-wheeling, $4-billion industry. Some have become havens for nurses who hopscotch from place to place to avoid the consequences of their misconduct."

7 Dec 2009

New data from Allos Therapeutics' FOLOTYN trial for PTCL

Allos Therapeutics, Inc. today reported a new analysis of data from the Company’s pivotal PROPEL trial of FOLOTYN™ (pralatrexate injection) in patients with relapsed or refractory peripheral T-cell lymphoma (PTCL). This indication is based on overall response rate. Clinical benefit such as improvement in progression free survival or overall survival has not been demonstrated.

7 Dec 2009

VELCADE based regimens are cost-effective for payers and patients, finds study

Millennium: The Takeda Oncology Company today announced that two studies presented at the 51st American Society of Hematology (ASH) Annual Meeting found that VELCADE based regimens are more cost-effective for payers and reduced out-of-pocket costs for patients than other commonly used multiple myeloma treatments.

7 Dec 2009

Nursing News and Research

Latest Nursing News and Research

CSL Behring selects BioRx as an approved Berinert provider

Utah project seeks to reduce 'overuse of health care'

Moses Cone Health System to implement Streamline Health Solutions' enterprise technology

Clinical trial results of VELCADE based combinations for MM to be presented at the ASH meeting

Experts attribute increased demand for nursing jobs to rise in pediatric specialty services

Study data of REVLIMID-dexamethasone combination therapy for high-risk smoldering multiple myeloma

ISST researchers develop software for physicians to have weekly 'Wound Conference'

Study results comparing REVLIMID regimen to stem cell transplant in multiple myeloma patients

Human blood stem cells can be engineered to kill HIV-infected cells, find researchers

New pharmacology textbook released by Elsevier

Workforce Alliance receives $134,790 grant to fund workforce training program

Investigation: Temp firms often employ incompetent nurses

New data from Allos Therapeutics' FOLOTYN trial for PTCL

VELCADE based regimens are cost-effective for payers and patients, finds study

New analyses of data from Allos Therapeutics’ pivotal PROPEL trial of FOLOTYN reported

Deal time? Key Senate Dems meet on public option in health bill

Crescent Healthcare CIO selected as finalist for 'Chief Innovation Officer' Appy Award

United Country Lippard Auctioneers announces the public auction of former Kingfisher Regional Hospital

First lifestyle magazine and website for nurses launched

ACP pleased with affordable coverage for all Americans, expresses concern regarding several provisions

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Nursing News and Research

Latest Nursing News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in